Search Results 711-720 of 17617 for Lemon juice

  1. A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach - Mayo Clinic

    A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach.

  2. Publications - Search Publications by Mayo Clinic Authors - Mayo Clinic Research

    "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical ...

  3. Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301 - Mayo Clinic

    The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an ...

  4. Mayo Clinic

    Recently, Julie Mai and Stephanie Steffen were sent by helicopter to check on an expectant mother at a remote clinic. They quickly realized that the baby's life ...

  5. Ear infection (middle ear) - Doctors and departments - Mayo Clinic

    These usually get better on their own, but sometimes medicine is needed. Find out more about how doctors diagnose and treat this common ear condition.

  6. A Study Of Airway Mycobiome In Inflammation And Chronic Infections In Bronchiectasis - Mayo Clinic

    The purpose of this study is to investigate the relationship between inflammatory endotypes of NCFB and the airway mycobiome. We hypothesize that patients with ...

  7. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

    Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study · Share ...

  8. A Study To Evaluate The Efficacy And Safety Of ABBV-8E12 In Subjects With Early Alzheimer's Disease - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

    Tremelimumab and MEDI4736 will be tested with MEDI6469 in a set of subjects with advanced solid tumors while rituximab will be tested with MEDI6469 in subjects ...

  10. A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW) - Mayo Clinic

    About this study. The purpose of the study is to compare once-weekly carfilzomib dosing in combination with dexamethasone to twice-weekly carfilzomib dosing ...